Switzerland: Management Syngenta Appointed New Independent Director

Editor: Alexander Stark

At Syngenta's General Shareholders’ Meeting, Dr. Eveline Saupper, member of the Board of Directors since 2013, stepped down as an Independent Director. Dr. Sophie Kornowski was newly elected to the Board as an Independent Director.

Related Vendors

Syngenta made changes to its Board.
Syngenta made changes to its Board.
(Source: Syngenta)

Basel/Switzerland — Dr. Kornowski, a French citizen, served as Executive Vice-President of Roche Partnering and was a member of the Roche Extended Corporate Executive Committee as well as a member of the board of Chugai. Later in the year, Kornowski will be joining a major healthcare investment fund headquartered in Cambridge, Massachusetts, as its Senior Partner. Before joining Roche in 2007, Dr. Kornowski held several management positions at Merck Sharp & Dome, Sanofi Winthrop and Abbott Diagnostics and Abbott Pharmaceutical Products. She holds a Doctorate in pharmacy from the Faculty of Pharmacy at Paris V, and an MBA from the University of Chicago Booth, Graduate School of Business.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent